Price movement over the last 24 hours
Acadia Healthcare Company Inc vs Visa Inc — how do they compare? Acadia Healthcare Company Inc trades at $30.84 (market cap $2.94B), while Visa Inc trades at $347.66 (market cap $669.79B). The key difference: Visa Inc is far larger — about 227.8× Acadia Healthcare Company Inc's market cap, and Visa Inc pays a 0.76% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | V | |
|---|---|---|
Market Cap | $2.94B | $669.79B |
Sector | Health | Financials |
52-Week High | $31.92 | $362.13 |
52-Week Low | $11.68 | $295.52 |
Enterprise Value | $5.45B | $680.39B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.76% |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Visa (V) trades at $347.27, down 2.79% on the day, amid a bullish technical setup with strong moving average signals. The company maintains robust fundamentals with a 51.68% net income margin and consistent earnings beats. Recent news highlights Visa's expansion into AI-driven commerce and stablecoin partnerships, positioning it for future growth. Institutional ownership remains strong, with multiple firms increasing stakes in Q4 2025.
Outlook remains positive with a consensus price target of $392.50, implying 13% upside. Risks include fintech competition and regulatory pressures, but Visa's dominant market position and high profitability support long-term investment appeal. The stock offers a balanced opportunity for growth-oriented investors seeking stable returns.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →